Virmedex beneficiary of the European Women TechEU Cohort
CEO Dani Tost selected among Europe's top female tech founders, securing an exclusive growth accelerator grant.
BRUSSELS / BARCELONA //
The European Innovation Council has officially announced that Dr. Daniela Tost, CEO of Virmedex, has been selected as a beneficiary of the highly competitive Women TechEU scheme.
The initiative supports deep-tech startups led by women, providing non-dilutive financial support alongside premium coaching and corporate networking.
Out of hundreds of applications across Europe, Virmedex’s cloud-based clinical simulation framework was highly commended for its technical merit and social impact.
More news
Virmedex Beneficiary of the European Women TechEU Cohort
Virmedex is officially selected as a winner of the highly competitive EU-funded Women TechEU initiative. The program awards CEO Dani Tost a non-dilutive scale-up grant and high-level mentorship celebrating women trailblazers in deep-tech.
Read the article →Virmedex Launches Dex: The First Perfusion AI Chatbot
Virmedex, an emerging innovator in medical simulation training, has announced the introduction of Dex, an All-things Perfusion AI Chatbot.
Read the article →Las Universidades en el Mobile World Congress​
Una spin-off creada junto con la UB que desarrolla juegos serios para la formación especializada en el ámbito médico. Un ejemplo es la plataforma para el entrenamiento en bypass cardiopulmonar (CPB) para comprender cómo hacer funcionar la bomba de circulación extracorpórea como si se estuviera dentro del quirófano.
Read the article →